Adiponectin‐mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis
- 18 June 2010
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (10) , 2886-2899
Abstract
Objective: Rheumatoid arthritis (RA) is associated with increased production of adipokines, which are cytokine‐like mediators that are produced mainly in adipose tissue but also in synovial cells. Since RA synovial fibroblasts (RASFs), lymphocytes, endothelial cells, and chondrocytes are key players in the pathophysiology of RA, this study was undertaken to analyze the effects of the key adipokine adiponectin on proinflammatory and prodestructive synovial effector cells.Methods: Lymphocytes were activated in part prior to stimulation. All cells were stimulated with adiponectin, and changes in gene and protein expression were determined by Affymetrix and protein arrays. Messenger RNA and protein levels were confirmed using semiquantitative reverse transcription–polymerase chain reaction (PCR), real‐time PCR, and immunoassays. Intracellular signal transduction was evaluated using chemical signaling inhibitors.Results: Adiponectin stimulation of human RASFs predominantly induced the secretion of chemokines, as well as proinflammatory cytokines, prostaglandin synthases, growth factors, and factors of bone metabolism and matrix remodeling. Lymphocytes, endothelial cells, and chondrocytes responded to adiponectin stimulation with enhanced synthesis of cytokines and various chemokines. Additionally, chondrocytes released increased amounts of matrix metalloproteinases. In RASFs, adiponectin‐mediated effects were p38 MAPK and protein kinase C dependent.Conclusion: Our previous findings indicated that adiponectin was present in inflamed synovium, at sites of cartilage invasion, in lymphocyte infiltrates, and in perivascular areas. The findings of the present study indicate that adiponectin induces gene expression and protein synthesis in human RASFs, lymphocytes, endothelial cells, and chondrocytes, supporting the concept of adiponectin being involved in the pathophysiologic modulation of RA effector cells. Adiponectin promotes inflammation through cytokine synthesis, attraction of inflammatory cells to the synovium, and recruitment of prodestructive cells via chemokines, thus promoting matrix destruction at sites of cartilage invasion.Keywords
This publication has 46 references indexed in Scilit:
- Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblastsBiochemical and Biophysical Research Communications, 2009
- Adiponectin as an anti-inflammatory factorClinica Chimica Acta, 2007
- Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serumAnnals of the Rheumatic Diseases, 2007
- Cells of the synovium in rheumatoid arthritis. Synovial fibroblastsArthritis Research & Therapy, 2007
- Developments in the synovial biology field 2006Arthritis Research & Therapy, 2007
- A role for leptin in rheumatic diseases?Annals of the Rheumatic Diseases, 2003
- Activin A induces cell proliferation of fibroblast‐like synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2003
- Identification of differentially expressed genes in rheumatoid arthritis by a combination of complementary DNA array and RNA arbitrarily primed-polymerase chain reactionArthritis & Rheumatism, 2002
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986